:

Yangyang Ou1, Yiyu Chen1, Kang Chen1

  • 1Department of General Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China.

American journal of surgery
|September 12, 2025
PubMed
概括

转化疗法可以改善不可切除的肝细胞癌 (uHCC) 的结果. 结合肝动脉输液化疗 (HAIC),氨酸激酶抑制剂 (TKI) 和免疫检查点抑制剂 (ICI) 的三重疗法对肝癌患者显示出有前途的结果.